Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. Although coronavirus disease-19 (COVID-19) affects every population group, the sports community and athletes require special consideration of the effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems. A comprehensive understanding of imaging indications, findings, and features of COVID-19 supports appropriate imaging utilization and effective patient management and treatment.
Purpose:
To review the spectrum of sports imaging in COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes.
Study Design:
Narrative review.
Level of Evidence:
Levels 4 and 5.
Methods:
Based on a PubMed database search, studies describing the imaging findings of COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes were included.
Results:
On March 11, 2020, World Health Organization officially declared COVID-19 a global pandemic. As of May 9, 2022, more than 515 million confirmed cases of COVID-19 were reported globally. While the multisystem effects of COVID-19 are incompletely understood, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. In the respiratory system, imaging plays an important role in diagnosing, characterizing, and monitoring pulmonary COVID-19 infections, barotrauma, and COVID-19-associated chronic pulmonary opacities and fibrotic-like lung changes. Ultrasonography, computed tomography, and magnetic resonance imaging aid in the timely diagnosis of ischemic, embolic, and thrombotic peripheral and central cardiovascular events, including deep venous thrombosis, pulmonary embolism, myocarditis, and stroke. COVID-19-associated musculoskeletal and peripheral nervous system manifestations include rhabdomyolysis and myonecrosis, plexus and peripheral neuropathies, Guillain-Barré syndrome, and shoulder injury related to vaccine administration.
Conclusion:
In athletes, COVID-19 infections and associated effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems require special consideration. With the increasing understanding of the multisystem effects of COVID-19, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. A comprehensive understanding of imaging indications, COVID-19 imaging features, and organ system effects aids in appropriate imaging utilization and effective patient management and treatments.
Al-MaqbaliJSAl RasbiSKashoubMS, et al. A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. Am J Case Rep. 2021;22:e932946.
2.
AllenLMHassoANHandwerkerJFaridH. Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics. 2012;32:1285-1297; discussion 1297-1289.
3.
AlrubayeRChoudhuryH. Severe rhabdomyolysis in a 35-year-old woman with COVID-19 due to SARS-CoV-2 infection: a case report. Am J Case Rep. 2020;21:e926733.
4.
Álvarez-TroncosoJRamos-RupertoLFernández-CidónP, et al. Screening protocol and prevalence of venous thromboembolic disease in hospitalized patients with COVID-19. J Ultrasound Med. Published online October 25, 2021. doi: 10.1002/jum.15850.
5.
AmmiratiECavalottiCMilazzoA, et al. Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. Int J Cardiol Heart Vasc. 2021;34:100774.
6.
AsmatHFayeyeFAlshakatyHPatelJ. A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Rep. 2021;14.
7.
BaiYYaoLWeiT, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323:1406-1407.
8.
Borku UysalBIkitimurHYavuzerSIslamogluMSCengizM. Case report: a COVID-19 patient presenting with mild rhabdomyolysis. Am J Trop Med Hyg. 2020;103:847-850.
9.
Cantarelli RodriguesTHidalgoPFSkafAYSerfatyA. Subacromial-subdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA). Skeletal Radiol. 2021;50:2293-2297.
10.
CaressJBCastoroRJSimmonsZ, et al. COVID-19-associated Guillain-Barré syndrome: the early pandemic experience. Muscle Nerve. 2020;62:485-491.
11.
ChedidNRUditSSolhjouZ, et al. COVID-19 and rhabdomyolysis. J Gen Intern Med. 2020;35:3087-3090.
12.
ChenLDengCChenX, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98:e951-e959.
13.
ChenRLiangWJiangM, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158:97-105.
14.
ChungMKZidarDABristowMR, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128:1214-1236.
15.
ClarkDEParikhADendyJM, et al. COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation. 2021;143:609-612.
16.
ClavijoMMVicente ReparazMLARuizJI, et al. Mild COVID-19 illness as a risk factor for venous thromboembolism. Cureus. 2021;13:e18236.
17.
CorrêaDGCañeteLAQDos SantosGAC, et al. Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: cause or coincidence?Clin Imaging. 2021;80:348-352.
18.
DanielsCJRajpalSGreenshieldsJT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 cardiac registry. JAMA Cardiol. 2021:6:1078-1087.
19.
DanssaertZRaumGHemtasilpaS. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus. 2020;12:e9698.
20.
DautyMMenuPFouasson-ChaillouxA. Effects of the COVID-19 confinement period on physical conditions in young elite soccer players. J Sports Med Phys Fitness. 2021;61:1252-1257.
21.
DisserNPDe MicheliAJSchonkMM, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102:1197-1204.
22.
DrigginEMadhavanMVBikdeliB, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352-2371.
23.
EgbertARCankurtaranSKarpiakS. Brain abnormalities in COVID-19 acute/subacute phase: a rapid systematic review. Brain Behav Immun. 2020;89:543-554.
24.
FernandezCEFranzCKKoJH, et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021;298:e117-e130.
25.
FosterAKhanZSiddiquiA, et al. It’s complicated: a case report on a COVID-19-positive HIV patient presenting with rhabdomyolysis and acute kidney injury. SAGE Open Med Case Rep. 2020;8:2050313x20965423.
Gallo MarinBAghagoliGLavineK, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31:1-10.
28.
GervasiSFPengueLDamatoL, et al. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?Br J Sports Med. 2021;55:54-61.
29.
GriffithJF. Musculoskeletal complications of severe acute respiratory syndrome. Semin Musculoskelet Radiol. 2011;15:554-560.
30.
GuarracinoFVetrugnoLForforiF, et al. Lung, heart, vascular, and diaphragm ultrasound examination of COVID-19 patients: a comprehensive approach.J Cardiothorac Vasc Anesth. 2021;35:1866-1874.
31.
GuoTFanYChenM, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-818.
32.
HanXFanYAlwalidO, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177-E186.
33.
HuangCHuangLWangY, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-232.
34.
HuangCWangYLiX, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
35.
HullJHWoottenMMoghalM, et al. Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: the UK experience. Br J Sports Med. 2022;56:4-11.
36.
HusainRCorcuera-SolanoIDayanEJacobiAHHuangM. Rhabdomyolysis as a manifestation of a severe case of COVID-19: a case report. Radiol Case Rep. 2020;15(9):1633-1637.
37.
HwangJLeeSBLeeSW, et al. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines. J Autoimmun. 2021;122:102681.
38.
IbarrolaMDávolosI. Myocarditis in athletes after COVID-19 infection: the heart is not the only place to screen. Sports Med Health Sci. 2020;2:172-173.
39.
KaminetzkyMMooreWFansiwalaK, et al. Pulmonary embolism at CT pulmonary angiography in patients with COVID-19. Radiol Cardiothorac Imaging. 2020;2:e200308.
40.
KangYChenTMuiD, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132-1141.
41.
KaulenLDDoubrovinskaiaSMooshageC, et al. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur J Neurol. 2022;29:555-563.
42.
KimHWJenistaERWendellDC, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6:1196-1201.
43.
KimJHLevineBDPhelanD, et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6:219-227.
44.
KleinebergNNKnaussSGülkeE, et al. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients - results of the European multinational LEOSS registry. Eur J Neurol. 2021;28:3925-3937.
45.
KremerSLersyFAnheimM, et al. Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. 2020;95:e1868-e1882.
46.
KremerSLersyFde SèzeJ, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297:e242-e251.
47.
LauEMChanFWHuiDSWuAKLeungPC. Reduced bone mineral density in male severe acute respiratory syndrome (SARS) patients in Hong Kong. Bone. 2005;37:420-424.
48.
LiLQHuangTWangYQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577-583.
49.
LongBBradyWJKoyfmanAGottliebM. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38:1504-1507.
50.
López-GonzálezMDPeral-GarridoMLCalabuigI, et al. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. Published online May 29, 2020. doi: 10.1136/annrheumdis-2020-217914.
51.
LuCHTsangYMYuCW, et al. Rhabdomyolysis: magnetic resonance imaging and computed tomography findings. J Comput Assist Tomogr. 2007;31:368-374.
52.
MakkatSVandevenneJEVerswijvelG, et al. Signs of acute stroke seen on fluid-attenuated inversion recovery MR imaging. AJR Am J Roentgenol. 2002;179:237-243.
53.
MałekŁAMarczakMMiłosz-WieczorekB, et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J Magn Reson Imaging. 2021;53:1723-1729.
54.
MalikBKalantaryARikabiKKunadiA. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021;14.
55.
MansourJShortRGBhallaS, et al. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clin Imaging. 2021;78:247-249.
56.
MartinezMWTuckerAMBloomOJ, et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021;6:745-752.
57.
Martins-FilhoPRPereiradeAndradeALPereiradeAndradeAJ, et al. Miller Fisher syndrome in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review. J Clin Neurol. 2021;17:541-545.
58.
McGuinnessGZhanCRosenbergN, et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020;297:e252-e262.
59.
McKinneyJConnellyKADorianP, et al. COVID-19-myocarditis and return to play: reflections and recommendations from a Canadian working group. Can J Cardiol. 2020;37:1165-1174.
60.
MehraeenEBehnezhadFSalehiMA, et al. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2021;278:307-312.
61.
MelliGChaudhryVCornblathDR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005;84:377-385.
62.
MokhtariTHassaniFGhaffariN, et al. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51:613-628.
63.
MontgomeryJRyanMEnglerR, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021 ;6:1202-1206.
64.
MoonisGFilippiCGKirschCFE, et al. The spectrum of neuroimaging findings on CT and MRI in adults with COVID-19. AJR Am J Roentgenol. 2021;217:959-974.
65.
MotaganahalliRLKapoorRTimsinaLR, et al. Clinical and laboratory characteristics of patients with COVID-19 infection and deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;9:605-614.e2.
66.
MoulsonNPetekBJDreznerJA, et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation. 2021;144:256-266.
67.
MyallKJMukherjeeBCastanheiraAM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18:799-806.
68.
NalbandianASehgalKGuptaA, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-615.
69.
NiazkarHRZibaeeBNasimiABahriN. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;41:1667-1671.
70.
OxleyTJMoccoJMajidiS, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382:e60.
71.
PanigadaMBottinoNTagliabueP, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738-1742.
72.
ParasherA. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 2021;97:312-320.
73.
ParisiSBorrelliRBianchiSFusaroE. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2:e655-e657.
74.
ParkJYKimJHLeeIJ, et al. COVID-19 vaccine-related interstitial lung disease: a case study. Thorax. 2021;77:102-104.
75.
PellicciaASharmaSGatiS, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42:17-96.
76.
PetersenSEFriedrichMGLeinerT, et al. Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc Imaging. 2021;15:685-699.
77.
PhelanDKimJHElliottMD, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. JACC Cardiovasc Imaging. 2020;13:2635-2652.
78.
RadmaneshADermanALuiYW, et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297:E223-E227.
79.
RamaniSLSametJFranzCK, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;50:1763-1773.
80.
RevzinMVRazaSSrivastavaNC, et al. Multisystem imaging manifestations of COVID-19, Part 2: from cardiac complications to pediatric manifestations. Radiographics. 2020;40:1866-1892.
81.
RevzinMVRazaSWarshawskyR, et al. Multisystem imaging manifestations of COVID-19, Part 1: viral pathogenesis and pulmonary and vascular system complications. Radiographics. 2020;40:1574-1599.
82.
Rodriguez-MoralesAJCardona-OspinaJAGutiérrez-OcampoE, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.
83.
RubinGDRyersonCJHaramatiLB, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Radiology. 2020;296:172-180.
84.
SalahHMMehtaJL. COVID-19 vaccine and myocarditis. Am J Cardiol. 2021;157:146-148.
85.
SantosREAda SilvaMGdo Monte SilvaMCB, et al. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: a systematic review. Am J Otolaryngol. 2021;42:102889.
86.
SeshadriDRThomMLHarlowERDrummondCKVoosJE. Case report: return to sport following the COVID-19 lockdown and its impact on injury rates in the german soccer league. Front Sports Act Living. 2021;3:604226.
87.
ShiSQinMShenB, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810.
88.
SinghBKaurPMechineniAMaroulesM. Rhabdomyolysis in COVID-19: report of four cases. Cureus. 2020;12:e10686.
89.
SnapiriORosenberg DanzigerCShirmanN, et al. Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. Pediatr Infect Dis J. 2021;40:e360-e363.
90.
SolísJGEsquivel PinedaAAlberti MinuttiPAlbarrán SánchezA. Case report: rhabdomyolysis in a patient with COVID-19: a proposed diagnostic-therapeutic algorithm. Am J Trop Med Hyg. 2020;103:1158-1161.
91.
StarekovaJBluemkeDABradhamWS, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6:945-950.
92.
StarekovaJBluemkeDABradhamWS, et al. Myocarditis associated with mRNA COVID-19 vaccination. Radiology. 2021;301:e409-e411.
93.
TaleSGhoshSMeiteiSP, et al. Post-COVID-19 pneumonia pulmonary fibrosis. QJM. 2020;113:837-838.
94.
TaxbroKKahlowHWulcanHFornarveA. Rhabdomyolysis and acute kidney injury in severe COVID-19 infection. BMJ Case Rep. 2020;13:e237616.
95.
ToresdahlBGAsifIM. Coronavirus disease 2019 (COVID-19): considerations for the competitive athlete. Sports Health. 2020;12:221-224.
96.
Torrealba-AcostaGMartinJCHuttenbachY, et al. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021;14:e243173.
97.
TufanoARendinaDAbateV, et al. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: a systematic review with meta-analysis.J Clin Med. 2021;10:4925.
98.
UmakanthanSSahuPRanadeAV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96:753-758.
99.
Valente-AcostaBMoreno-SanchezFFueyo-RodriguezOPalomar-LeverA. Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19. BMJ Case Rep. 2020;13:e236719.
100.
van LangenHSchramaCAvan GinkelGRankeGLevineYK. Order and dynamics in the lamellar L alpha and in the hexagonal HII phase. Dioleoylphosphatidylethanolamine studied with angle-resolved fluorescence depolarization. Biophys J. 1989;55:937-947.
101.
VidulaMKAmbroseMGlassbergH, et al. Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus. 2021;13:e15576.
102.
WangDHuBHuC, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
103.
WangRLChiangWFShyuHY, et al. COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM. 2021;114:506-507.
104.
WendlingDVerhoevenFChoukMPratiC. Can SARS-CoV-2 trigger reactive arthritis?Joint Bone Spine. 2021;88:105086.
WooEJMba-JonasADimovaRB, et al. Association of receipt of the Ad26.COV2.S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA. 2021;326:1606-1613.
107.
WuZMcGooganJM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242.
108.
YangWSirajuddinAZhangX, et al. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). Eur Radiol. 2020;30:4874-4882.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
111.
ZhouYHeYYangH, et al. Development and validation a nomogram for predicting the risk of severe COVID-19: a multi-center study in Sichuan, China. PLoS One. 2020;15:e0233328.
112.
ZhuJZhongZJiP, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020;8:e000488.
113.
ZuttRvan der KooiAJLinthorstGEWandersRJde VisserM. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24:651-659.
